Company Overview
Snapshot
Founded in January 2005 by Alex Shoenfeld, BioPad operates with 1–10 employees. The company is currently in a Pre-Funding stage.
Business overview
BioPad develops a noninvasive device designed to accurately monitor fetal activity in pregnant women from week 24 through birth. Its core technology involves a passive device that emits no radiation, ensuring safety for home use. The product utilizes disposable pads for real-time fetal movement indication and stores historical data, which can be accessed by the mother and downloaded by physicians via USB or email. BioPad serves the healthcare industry, specifically targeting expectant mothers and medical providers, operating within the Digital Healthcare and Medical Devices sectors, with a focus on Patient Remote Monitoring and Medical Monitors.
Log in to access full profile ›Company Intelligence Q&A
- What is BioPad's primary product?
- BioPad's primary product is a noninvasive device designed to accurately monitor fetal activity in pregnant women from week 24 through birth, providing a reliable means of monitoring fetal activity at home.
- What is the core technology behind BioPad's device?
- The core technology involves passive, disposable pads that emit no radiation, making them safe for home use. These pads are used by expectant mothers for 20 minutes at a time to track fetal movements.
- How does BioPad's device provide data to users and clinicians?
- The device provides real-time indications of fetal movements to the mother and stores the movement history. Physicians can download collected data directly from the device via a USB port, or mothers can send the data via email.
- When was BioPad founded?
- BioPad was founded in January 2005.
- Who is a key founder of BioPad?
- Alex Shoenfeld is a founder and the CSO & Director of BioPad.